Beijing Tongrentang Co., Ltd (SHA:600085)

China · Delayed Price · Currency is CNY

30.77

+0.19 (0.62%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Science Company	7.26B	-	-						-	-
Commerce Company	10.62B	-	-						-	-
Offset of Business Segment	-5.56B	-	-						-1.43B	-1.33B
Others	1.38B	-	-						74.10M	71.16M
Others Growth	-	-	-						4.12%	-
The Company	4.90B	-	-						-	-
Manufacturing Division	-	-	-						7.52B	6.82B
Manufacturing Division Growth	-	-	-						10.21%	-
Drug retail segment	-	-	-						5.93B	5.34B
Drug retail segment Growth	-	-	-						11.09%	-
Total	18.60B	-	-						12.09B	10.90B
Total Growth	-	-	-						10.96%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	17.14B	-	-						11.27B	10.15B
China Growth	-	-	-						11.09%	-
Overseas	1.34B	-	-						743.71M	655.61M
Overseas Growth	-	-	-						13.44%	-
Total	18.49B	-	-						12.02B	10.80B
Total Growth	-	-	-						11.24%	-

Source: S&P Global Market Intelligence.